Terms: = Colorectal cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL
174 results:
1. Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy and biologics in the US.
Paly VF; Dasari A; Hubbard J; Bekaii-Saab T; Padukkavidana T; Hernandez L
J Comp Eff Res; 2024 Aug; 13(8):e240084. PubMed ID: 38976346
[No Abstract] [Full Text] [Related]
2. Dual-mRNA Delivery Using Tumor Cell Lysate-Based Multifunctional Nanoparticles as an Efficient Colon cancer Immunogene Therapy.
Wang K; Gao Y; Wu S; Zhang J; Zhu M; Chen X; Fu X; Duan X; Men K
Int J Nanomedicine; 2024; 19():4779-4801. PubMed ID: 38828196
[TBL] [Abstract] [Full Text] [Related]
3. Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
Quintanilha JCF; Sibley AB; Liu Y; Niedzwiecki D; Halabi S; Rogers L; O'Neil B; Kindler H; Kelly W; Venook A; McLeod HL; Ratain MJ; Nixon AB; Innocenti F; Owzar K
BMC Genomics; 2024 May; 25(1):473. PubMed ID: 38745123
[TBL] [Abstract] [Full Text] [Related]
4. Nanographene-Au fine-tuning to intensify plasmonic-resonance of polymeric hybrid bionanosystem for synergistic phototherapy and nerve photobiomodulation.
Jaswal R; Kumar D; Rezk AI; Kaliannagounder VK; Park CH; Min KH
Colloids Surf B Biointerfaces; 2024 May; 237():113820. PubMed ID: 38502975
[TBL] [Abstract] [Full Text] [Related]
5. A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming K-ras mutations and drug resistance in colorectal carcinoma.
Song H; Li H; Shen X; Liu K; Feng H; Cui J; Wei W; Sun X; Fan Q; Bao W; Zhou H; Qian L; Nie H; Cheng X; Du Z
Acta Biomater; 2024 Mar; 177():456-471. PubMed ID: 38331131
[TBL] [Abstract] [Full Text] [Related]
6. Efficient Colon cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles.
Huang J; Wang K; Fu X; Zhu M; Chen X; Gao Y; Ma P; Duan X; Men K
Int J Nanomedicine; 2023; 18():8059-8075. PubMed ID: 38164262
[TBL] [Abstract] [Full Text] [Related]
7. Establishment and Validation of a Postoperative VTE Prediction Model in Patients with colorectal cancer Undergoing Radical Resection: CRSPOT Nomogram.
Wu Y; Wang L; Yin Q; Deng L; Ma J; Tian X
Clin Appl Thromb Hemost; 2023; 29():10760296231216966. PubMed ID: 37997283
[TBL] [Abstract] [Full Text] [Related]
8. Psoralea corylifolia formula extract-loaded silk fibroin/polycaprolactone fibrous membrane for the treatment of colorectal cancer.
Feng Y; Han Z; Chen C; Wang X; Liu J; Khan Y; Xie M; Chen Y; Zhang Y; Li G
Colloids Surf B Biointerfaces; 2024 Jan; 233():113635. PubMed ID: 37976725
[TBL] [Abstract] [Full Text] [Related]
9. Improved antitumor activity through a tyramidyl maslinic acid derivative. Design and validation as drug-loaded electrospun polymeric nanofibers.
Luque C; de la Cabeza Fernández M; Fuentes-Rios D; Cepero A; Contreras-Cáceres R; Doña M; Perazzoli G; Lozano-Chamizo L; Filice M; Marciello M; Gonzalez-Rumayor V; López-Romero JM; Cabeza L; Melguizo C; Prados J
Eur J Pharm Biopharm; 2023 Dec; 193():241-253. PubMed ID: 37972906
[TBL] [Abstract] [Full Text] [Related]
10. Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers.
Pouya FD; Salehi R; Rasmi Y; Kheradmand F; Fathi-Azarbayjani A
Life Sci; 2023 Nov; 332():122083. PubMed ID: 37717622
[TBL] [Abstract] [Full Text] [Related]
11. Targeted delivery of panitumumab-scaffold bosutinib-encapsulated polycaprolactone nanoparticles for EGFR-overexpressed colorectal cancer.
Bhattacharya S; Parihar VK; Singh N; Hatware K; Page A; Sharma M; Prajapati MK; Kanugo A; Pawde D; Maru S; Gupta GL; Kanvinde S
Nanomedicine (Lond); 2023 Apr; 18(9):713-741. PubMed ID: 37309754
[No Abstract] [Full Text] [Related]
12. Assessment of Electrospun Poly(ε-caprolactone) and Poly(lactic acid) Fiber Scaffolds to Generate 3D In Vitro Models of colorectal Adenocarcinoma: A Preliminary Study.
Ricci C; Azimi B; Panariello L; Antognoli B; Cecchini B; Rovelli R; Rustembek M; Cinelli P; Milazzo M; Danti S; Lazzeri A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298394
[TBL] [Abstract] [Full Text] [Related]
13. Mechanistic insights into the anti-tumor and anti-metastatic effects of Patrinia villosa aqueous extract in colon cancer via modulation of TGF-β R1-smad2/3-E-cadherin and FAK-RhoA-cofilin pathways.
Yang H; Yue GG; Yuen KK; Gao S; Leung PC; Wong CK; Lau CB
Phytomedicine; 2023 Aug; 117():154900. PubMed ID: 37269754
[TBL] [Abstract] [Full Text] [Related]
14. Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of
Ejaz SA; Aziz M; Fawzy Ramadan M; Fayyaz A; Bilal MS
Molecules; 2023 May; 28(10):. PubMed ID: 37241785
[TBL] [Abstract] [Full Text] [Related]
15. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
16. Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-pcl hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells.
Shahidi S; Rostamizadeh K; Fathi M; Nedaei K; Ramazani A
BMC Complement Med Ther; 2022 Dec; 22(1):340. PubMed ID: 36575448
[TBL] [Abstract] [Full Text] [Related]
17. Racial/Ethnic and Sex Differences in Somatic cancer Gene Mutations among Patients with Early-Onset colorectal cancer.
Holowatyj AN; Wen W; Gibbs T; Seagle HM; Keller SR; Edwards DRV; Washington MK; Eng C; Perea J; Zheng W; Guo X
Cancer Discov; 2023 Mar; 13(3):570-579. PubMed ID: 36520636
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of anal pre-cancer screening strategies among men who have sex with men.
Sun J; Wiley D; Barrett BW; Hsu H; Palella FJ; Kwait J; Martinson J; D'Souza G
Int J STD AIDS; 2023 Feb; 34(2):87-97. PubMed ID: 36380689
[TBL] [Abstract] [Full Text] [Related]
19. Exosomes derived from human umbilical cord mesenchymal stem cells regulate lymphangiogenesis via the miR-302d-3p/vegfr3/AKT axis to ameliorate inflammatory bowel disease.
Zhang L; Yuan J; Kofi Wiredu Ocansey D; Lu B; Wan A; Chen X; Zhang X; Qiu W; Mao F
Int Immunopharmacol; 2022 Sep; 110():109066. PubMed ID: 35978512
[TBL] [Abstract] [Full Text] [Related]
20. [A prospective cohort study on the clinical value of pelvic peritoneal reconstruction in laparoscopic anterior resection for middle and low rectal cancer].
Ji LQ; Lou Z; Gong HF; Sui JK; Cao FA; Yu GY; Zhu XM; Zheng NX; Meng RG; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):336-341. PubMed ID: 35461202
[No Abstract] [Full Text] [Related]
[Next]
